본문으로 건너뛰기
← 뒤로

The Years 2015-2025 as a Prospective Decade for the Identification of Specific Methylation Biomarkers of Prostate Cancer.

1/5 보강
Biomolecules 📖 저널 OA 100% 2021: 1/1 OA 2022: 3/3 OA 2023: 3/3 OA 2024: 9/9 OA 2025: 58/58 OA 2026: 55/55 OA 2021~2026 2025 Vol.15(9)
Retraction 확인
출처

Selmani Z, Peixoto P, Overs A, Hervouet E

📝 환자 설명용 한 줄

For ten years, DNA methylation appeared as a major step in the understanding and issues of prostate cancers.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Selmani Z, Peixoto P, et al. (2025). The Years 2015-2025 as a Prospective Decade for the Identification of Specific Methylation Biomarkers of Prostate Cancer.. Biomolecules, 15(9). https://doi.org/10.3390/biom15091334
MLA Selmani Z, et al.. "The Years 2015-2025 as a Prospective Decade for the Identification of Specific Methylation Biomarkers of Prostate Cancer.." Biomolecules, vol. 15, no. 9, 2025.
PMID 41008642 ↗

Abstract

For ten years, DNA methylation appeared as a major step in the understanding and issues of prostate cancers. Indeed, although classical biochemical parameters are still useful for prostate cancer diagnosis, they have poor sensitivity and are not specific for prostate cancer subtypes. The recent boom in the identification of specific DNA methylation profiles and the rapid development of liquid biopsies have completely modified the care of patients and may greatly influence outcomes in the future. Indeed, DNA methylation modifications could substantially improve the diagnosis by identifying specific prostate subtypes, improve follow-up to monitor residual disease, improve therapeutic efficiency by predicting the response to treatment, and improve the health quality of patients since these epigenetic modifications can easily be detected in non-invasive liquid biopsies.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기